Using the EXOPULSE Mollii suit to improve motor function in multiple sclerosis patients
Effectiveness of the EXOPULSE Mollii Ⓡ Suit in Patients With Multiple Sclerosis: Randomized Clinical Trial
This study is testing if wearing the EXOPULSE Mollii suit can help people with multiple sclerosis improve their movement and balance.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 22 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Universidad Europea de Madrid Academic / other |
| Locations | 1 site (Villaviciosa De Odón, Madrid) |
| Trial ID | NCT06384729 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of the EXOPULSE Mollii suit, which provides non-invasive electrical stimulation, in enhancing motor control for patients with multiple sclerosis (MS). The study involves a randomized, double-blind design where participants will be assigned to receive either active or inactive treatment for three weeks. Key outcome measures include improvements in pain, balance, gait speed, and overall motor function. The trial aims to provide insights into the suit's potential benefits for individuals suffering from the debilitating effects of MS.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older diagnosed with multiple sclerosis and scoring between 2 and 4 on the Functional Ambulation Category.
Not a fit: Patients who are pregnant, have an intrathecal baclofen pump, or have received botulinum toxin injections in the last three months may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve motor function and quality of life for patients with multiple sclerosis.
How similar studies have performed: While the EXOPULSE Mollii suit has shown benefits in other neurological conditions, its application in multiple sclerosis is relatively novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Diagnosis of Multiple Sclerosis as confirmed by a physician using McDonald's criteria. * Age over 18 years. * Ability to comprehend verbal commands. * Scoring between 2 and 4 on the Functional Ambulation Category (FAC). Exclusion Criteria: * Pregnancy. * Having an intrathecal baclofen pump. * Having received botulinum toxin injections in the last 3 months. * Wearing electronic or magnetic medical devices (pacemakers, shunts, etc.) that may be affected by magnets. * BMI \> 35.
Where this trial is running
Villaviciosa De Odón, Madrid
- Cecilia Estrada Barranco — Villaviciosa De Odón, Madrid, Spain (Recruiting)
Study contacts
- Study coordinator: Cecilia Estrada Barranco, PhD
- Email: cecilia.estrada@universidadeuropea.es
- Phone: 917 40 72 72
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.